Aspirin/Phenacetin/Caffeine

阿司匹林/非那西丁/咖啡因

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAspirin/Phenacetin/Caffeine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsCyclooxygenasesAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsHeadacheFeverDysmenorrhea +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AspirinPhenacetinCaffeine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHeadacheFeverDysmenorrhea +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN02BA51
Related LinksN/A